Role of SGLT2 inhibitors beyond diabetes care to metabolic care: Indian Perspective
India: A recent article published in the Indian Journal of Endocrinology and Metabolism has presented an Indian perspective on the paradigm shift of SGLT2 inhibitors from diabetes care to metabolic care. The study revealed that sodium-glucose co-transporter 2 (SGLT2) inhibitors, with their several pleiotropic benefits, have received considerable attention recently as a novel class of […]